7 Industry Leaders Weigh In On Patient Engagement & Recruitment

Strides in technology and digital solutions are only as beneficial as the ecosystem and experiences they create for every person that drives their usage or development. With 1.4 million participants needed to meet enrollment requirements across today’s actively enrolling phase 3 studies, only 46% of studies that started in the past five years reported hitting their enrollment targets. The numbers tell their own story: Barriers still exist and work still needs to be done.

As we shift into the new year while continuing to write our individual and collective story, Citeline Connect gathered insight from leaders who each represent a unique facet of the clinical trial ecosystem. Through collaborative reflection, we hope to review the activities of this year and draw learnings to ensure successful trial outcomes and, most importantly, to shape a brighter future where people worldwide can live longer, healthier, more hopeful lives.